Skip to content

Oral Symptom Assessment Scale (OSAS): Validity and Reliability

Oral Symptom Assessment Scale (OSAS): Validity and Reliability

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04932317
Enrollment
54
Registered
2021-06-21
Start date
2021-08-05
Completion date
2022-08-30
Last updated
2023-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

Oral health, Oral care, Neoplasms, Palliative care

Brief summary

Oral (mouth) symptoms are very common and often bothersome in patients with cancer. The best way to assess these symptoms is using a patient-rated symptom assessment scale. A new symptom assessment scale for oral symptoms has been developed and already tested in patients. The purpose of this study is to test the scale again to make sure it is reliable and accurate.

Detailed description

Oral health is multifaceted and includes an individual's ability to speak, eat as well as to convey emotion without pain, embarrassment or discomfort. Oral health contributes to an individual's general well-being. Poor oral health in patients with advanced cancer can be associated with negative impacts on an individual's quality of life in terms of psychological and emotional distress (e.g. avoiding social interactions due to embarrassment) and physical distress (e.g. pain associated with mucositis). As well as this certain problems can be associated indirectly with mortality in patients with advanced cancer e.g. oral infection leading to systemic infection. In patients with advanced cancer oral symptoms are common, often multiple and of high-impact. Routine screening for oral symptoms should be undertaken in all patients with advanced cancer in conjunction with regular examination of the oral cavity to ensure correct diagnosis and adequate treatment. A novel oral symptom assessment scale (OSAS) was designed and developed to measure the frequency, severity and distress (or bother) of twenty oral symptoms in patients with advanced cancer. This initial observational study provided provisional validation of the new assessment tool. This study aims to further investigate the reliability and validity of this novel oral symptom assessment tool in patients with advanced cancer. Test-retesting will occur in patients deemed clinically stable. Test- retesting will be undertaken to measure reliability on two occasions 24-48 hours apart. Recruited patients will be asked to fill in the OSAS as well as the EORTC QLQ- C30 and EORTC QLQ-OH15 (a validated quality of life assessment with an oral health module) which will provide criterion (concurrent) validity.

Interventions

None listed

Sponsors

University of Dublin, Trinity College
CollaboratorOTHER
Our Lady's Hospice and Care Services
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any cancer diagnosis * Age ≥ 18 years old * Able to understand and speak English * Signed witnessed consent form * In the 'Stable' clinical phase

Exclusion criteria

* In the judgement of the Palliative Care physician, study participation is not appropriate * Unable to complete the study assessments in entirety i.e. in full at Time 1 ( 0 hours) and at Time 2 (24 hours later) * In the 'Unstable', 'Deteriorating' or 'Terminal' clinical phase

Design outcomes

Primary

MeasureTime frameDescription
To measure the reliability of the oral symptom assessment scale (i.e assess if any change)Measured at Time 1 ( Time 1 = 0 hours ) and Time 2 (Time = 24 hours later)The oral symptom assessment scale is a twenty-question patient-reported symptom assessment scale. Participants are asked to rate how often ( rarely, occasionally, frequently, almost constantly), the severity (slight, moderate, severe, very severe) and distress or bother ( not at all, a little bit, somewhat, quite a bit, very much) of any of these twenty oral symptoms during the past week.
To measure the concurrent validity of the OSAS against the EORTC QLQ-OH15Measured at Time 1 ( Time = 0 hours)The European Organisation for Research and Treatment of Cancer Quality of Life of cancer patients questionnaire is a patient-reported outcomes evaluation of quality of life in cancer patients and the European Organisation of Research and Treatment of Cancer Quality of Life Oral Health questionnaire is an oral health quality of life module. The former consists of thirty questions assessing five functions, nine symptoms and global health status/quality of life. The EORTC QLQ OH-15 module consists of one multi-item scale to assess oral health quality of life and five single items to assess sore mouth, sticky saliva, sensitivity, dentures and information.All of the scales and single-item measures range in score from 0 to 100.A high score for the functional scale and single item represents a high level of functioning, this is, a low level of symptomatology or problems. A high score for the symptom items represents a high level of symptomatology or problems.
To measure ease of useMeasured at Time 1 ( Time = 0 hours)Participants will be asked to fill in an ease of use questionnaire at Time point 1. The two questions will be yes or no answers ( 1. Did you think the OSAS was easy to complete? 2. Did you think the EORTC QLQ C30 and EORTC QLQ OH15 was easy to complete?)

Other

MeasureTime frameDescription
Ease of answering questionnaireAt Time 1 only ( Time 1 = 0 hours)Participants will be asked about how easy the questionnaires are to answer i.e the two questions posed are : Did you think Questionnaire 1 (OSAS) was easy to complete? Answer: Yes or No and Did you think Questionnaire 2 (EORTC QLQ-C30 and EORTC QLQ-OH15) was easy to complete? Answer: Yes or No

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026